A spatial map of MAPK-activated immunosuppressive myeloid populations in pediatric low-grade glioma
- 15 September 2025
- journal article
- resource
- Published by Springer Nature in Nature Immunology
- Vol. 26 (10) , 1794-1806
Abstract
Pediatric low-grade gliomas (pLGGs) are mitogen-activated protein kinase (MAPK) pathway-activated brain tumors prevalent in children and are associated with morbidity despite favorable survival. Here using imaging mass cytometry, we spatially characterized at the single-cell level the tumor microenvironment (TME) of 120 pLGG cases, considering age, molecular drivers, brain location and tumor subtype. Our analysis identified myeloid cells—including resident microglia and bone marrow-derived macrophages—as the predominant immune population in the TME, particularly in optic pathway tumors. Additionally, we discovered an immune signature predictive of progression-free survival. Spatial analysis identified specific cellular interactions, notably myeloid–myeloid contacts and macrophage-enriched regions harboring MAPK-activated, TIM-3+ myeloid cells, suggesting an immunosuppressive TME. Our study provides a comprehensive resource on the immune landscape of these pLGGs and underscores the immunosuppressive role of diverse myeloid infiltrates. These findings also indicate that combining TIM-3 blockade with MAPK inhibition might be a promising therapeutic strategy to target both the TME and oncogenic MAPK activation in pLGG tumors.Keywords
Funding Information
- Gouvernement du Canada | Canadian Institutes of Health Research (FDN-154307)
- Fondation Charles-Bruneau
- The Everest Centre for Low-grade Paediatric Brain Tumours
This publication has 67 references indexed in Scilit:
- The Microenvironmental Landscape of Brain TumorsCancer Cell, 2017
- The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomasScience, 2016
- MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint BlockadeImmunity, 2016
- Characterization of the Blood Brain Barrier in Pediatric Central Nervous System NeoplasmsJournal of Interdisciplinary Histopathology, 2016
- Factors Influencing the CNS Distribution of a Novel MEK-1/2 Inhibitor: Implications for Combination Therapy for Melanoma Brain MetastasesDrug Metabolism and Disposition, 2014
- Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytomaNature Genetics, 2013
- Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and HematologyNeuro-Oncology, 2012
- Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biologyJournal of Neurosurgery, 2011
- Survival and long-term health and cognitive outcomes after low-grade gliomaNeuro-Oncology, 2010
- Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic AstrocytomasCancer Research, 2008